Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2020-09-22
Original market date: See footnote 1
2020-09-22
Product name:
METHYLENE BLUE INJECTION
DIN:
02487993
Product Monograph/Veterinary Labelling:
Date:
2019-04-30
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
PHEBRA PTY LTD
19, Orion Road
Lane Cove West
New South Wales
Australia
2066
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
92:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V03AB17 METHYLTHIONINIUM CHLORIDE
Active ingredient group (AIG) number:See footnote5
0106816001
| Active ingredient(s) See footnote8 | Strength |
|---|---|
| METHYLENE BLUE | 10 MG / ML |